Retraction and republication-Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
- PMID: 30056841
- PMCID: PMC6900581
- DOI: 10.1016/S2213-8587(18)30146-3
Retraction and republication-Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
Retraction of
-
Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment.Lancet Diabetes Endocrinol. 2018 Feb;6(2):95-104. doi: 10.1016/S2213-8587(17)30366-2. Epub 2017 Nov 28. Lancet Diabetes Endocrinol. 2018. Corrected and republished in: Lancet Diabetes Endocrinol. 2018 Jun;6(6):e6-e15. doi: 10.1016/S2213-8587(18)30150-5. Retraction in: Lancet Diabetes Endocrinol. 2018 Jun;6(6):437. doi: 10.1016/S2213-8587(18)30146-3. PMID: 29195904 Free PMC article. Corrected and republished. Retracted.
References
-
- Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources